Current Headlines

81. Parker Domnick Hunter To Showcase New Integrated Processing Solution At INTERPHEX 2013
    3/29/2013

    Parker domnick hunter Process Filtration will unveil its first integrated single-use solution following the addition of Madison-based single-use innovator, SciLog at INTERPHEX 2013 in New York from April 23-25 (booth 3063). 

82. Leading Scientists Contribute To Ground-Breaking Toxicology Book
    3/29/2013

    The first new toxicology text to address both small and large molecules within the drug development process with contributions from leading scientists from around the globe is now available.

83. Omeros Announces Toxicology Data That Support Advancing MASP-2 Inhibitor Into Clinical Trials
    3/28/2013
84. Biodel Completes Enrollment In Phase 2 Clinical Trial Of Ultra-Rapid-Acting Insulin Candidate BIOD-123 For The Treatment Of Diabetes
    3/28/2013

    Biodel Inc. (Nasdaq:BIOD) today announced the completion of patient enrollment in a Phase 2 clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of diabetes. The trial will evaluate the use of BIOD-123 versus Humalog^® on measures of HbA1c, postprandial glucose excursions, glycemic variability, hypoglycemic event rates and weight changes.

85. Thermo Fisher Scientific Forms Technology Alliance Partnership With The University Of Birmingham, UK
    3/28/2013

    Thermo Fisher Scientific Inc., the world leader in serving science, has entered into a Technology Alliance Partner agreement with scientists at the University of Birmingham, UK, establishing a collaboration to accelerate research in high-resolution accurate mass (HRAM) and triple quadrupole liquid chromatography-mass spectrometry (LC-MS) for life science applications.

86. Marken Hosts Industry Panel Event In Mexico City
    3/28/2013

    Marken recently announced a life sciences panel event which will take place on April 11th to explore the key issues and challenges the industry faces with biologics and biosimilar trials in Latin America.

87. SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies
    3/27/2013

    The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder

88. PPD Expands cGMP Cell-Based Assay Laboratory
    3/27/2013

    Pharmaceutical Product Development, LLC (PPD) is expanding its cGMP cell-based assay laboratory in Middleton, Wis., to meet the growing needs of clients seeking to validate bioassays for product release and stability testing of biological products, both as novel drugs and as biosimilars

89. Biogen Idec’s TECFIDERA (Dimethyl Fumarate) Approved In US As A First-Line Oral Treatment For Multiple Sclerosis
    3/27/2013

    Recently Biogen Idec announced that the U.S. Food and Drug Administration (FDA) has approved TECFIDERA (dimethyl fumarate), a new first-line oral treatment for people with relapsing forms of multiple sclerosis (MS). 

90. Clipster Aseptic Disconnector Makes Aseptic Tubing Disconnection Easy
    3/26/2013

    Sartorius Stedim Biotech, a leading international supplier for the pharma and biotech industries, has launched new sizes XS and S of the Clipster Aseptic Disconnector, in addition to the existing size L.